UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) : August 12, 2003
EMISPHERE TECHNOLOGIES, INC.
------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-10615 13-3306985
- ------------------------------- ------------------------ ----------------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer Identification
incorporation) Number)
765 Old Saw Mill River Road,
Tarrytown, NY 10591
- ---------------------------------- ---------
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code: (914) 785-4701
Item 5. Other Events.
On August 12, 2003, registrant issued a joint press release entitled: "Lilly and
Emisphere continue development of oral PTH program, as Emisphere reacquires all
rights to oral rhGH", that announced that all rights previously obtained by Eli
Lilly and Company (NYSE:LLY) and data generated for the oral recombinant human
growth hormone (rhGH) program will be returned to the registrant.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits. 99.1 Press Release, dated August 12, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EMISPHERE TECHNOLOGIES, INC.
Date: August 14, 2003 By: /s/ FREDRICK D. COBB.
--------------------
Fredrick D. Cobb.
Principal Financial Officer